# Adipose Derived Regenerative Cellular Therapy of Chronic Wounds

> **NCT02092870** · PHASE2 · COMPLETED · sponsor: **Tower Outpatient Surgical Center** · enrollment: 25 (actual)

## Conditions studied

- Diabetic Foot
- Venous Ulcer
- Pressure Ulcer

## Interventions

- **DRUG:** Adipose derived stem cells

## Key facts

- **NCT ID:** NCT02092870
- **Lead sponsor:** Tower Outpatient Surgical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-09
- **Final completion:** 2019-09-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092870, "Adipose Derived Regenerative Cellular Therapy of Chronic Wounds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02092870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*